Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2

Peele, K.Abraham and Kumar, Vikas and Parate, Shraddha and Srirama, Krupanidhi and Lee, Keun Woo and Venkateswarulu, T.C. (2021) Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2. Journal of Pharmaceutical Sciences, 110 (6). pp. 2346-2354. ISSN 00223549

[thumbnail of 5-21.pdf] Text
5-21.pdf
Restricted to Registered users only

Download (1MB) | Request a copy

Abstract

In the present study, biosorption of lead using green algae as biosorbent from aqueous solution was studied with one-factor-
at-a-time (OFAT) method. The batch biosorption process is a function of agitation time, biomass loading, initial concentration
of lead and solution pH. Further, face-centered central composite design under RSM application was applied to optimize the process parameters to get more percentage biosorption of lead. The percentage removal of lead was found to be 71% in batch experiment by OFAT method, whereas in RSM study the maximum biosorption rate 75% was reached at optimum conditions of agitation time 40 min., dosage 3 g, initial ion concentration 15 mg/L and pH 3.35. The adsorbent was char-acterized by FTIR, scanning electron microscopy (SEM) and Brunauer–Emmett Teller (BET) analysis. The kinetic models
were also analyzed to determine the biosorption mechanism. It was found that the data best followed to pseudo second order
mechanism. Biosorption isotherms were successfully ftted by Langmuir isotherm (R2=0.974) and d) Freundlich isotherm
(R2=0.983) models.

Item Type: Article
Subjects: AC Rearch Cluster
Depositing User: Unnamed user with email techsupport@mosys.org
Date Deposited: 28 Dec 2023 04:42
Last Modified: 28 Dec 2023 04:42
URI: https://ir.vignan.ac.in/id/eprint/688

Actions (login required)

View Item
View Item